Trials / Completed
CompletedNCT05269537
Changes in Cardiac Output During Cesarean Delivery Under Spinal Anesthesia
Changes in Cardiac Output During Cesarean Delivery Under Spinal Anesthesia. A Prospective Observational Study Using Transthoracic Echocardiography
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- Female
- Age
- 19 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Cardiac output will be measured in healthy parturients undergoing cesarean delivery under spinal anesthesia
Detailed description
ASA-II women undergoing cesarean delivery under spinal anesthesia will be included. Cardiac output will be measured using transthoracic echocardiography at 4 time points: Baseline, after 10 minutes of intrathecal injection, after delivery, and after 1 hour of intrathecal injection. Spinal anesthesia will be administered with 2.5 ml bupivacaine 0.5% and fentanyl 15 μg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Transthoracic Echocardiography | Measurement of cardiac output in supine position with left lateral tilt at baseline, at 10 minutes after intrathecal injection, immediately after delivery, and at 1 hour after intrathecal injection |
| PROCEDURE | Spinal Anesthesia | Performed at the L3-L4 or L4-L5 interspace using 25-gauge spinal needle |
| DRUG | Intrathecal Bupivacaine | Bupivacaine 12.5 mg (2.5 mL 0.5%) will be administered in the subarachnoid space |
| DRUG | Intrathecal Fentanyl | Fentanyl 15 μg will be administered in the subarachnoid space |
| DRUG | Crystalloid Coload 1000 mL | Ringer acetate 1000 mL will be administered over 10 minutes starting immediately after intrathecal injection |
| PROCEDURE | Cesarean Delivery | Lower segment cesarean section using the Pfannenstiel incision and uterine exteriorization |
| DRUG | Intravenous Ephedrine | Intravenous ephedrine 3, 5, and 10 mg will be administered when Systolic blood pressure decreases below 90%, 80%, and 70% of baseline, respectively. |
| DRUG | Oxytocin | Intravenous oxytocin 10 U in 500 mL Ringer acetate will be administered over 30 minutes starting immediately after delivery of the fetus |
Timeline
- Start date
- 2022-03-12
- Primary completion
- 2022-07-02
- Completion
- 2022-07-02
- First posted
- 2022-03-08
- Last updated
- 2022-11-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05269537. Inclusion in this directory is not an endorsement.